Skip to main content
TipRanks
Go Ultimate75% OFF

Gregory Alan Korbel Insider Profile

4 Followers

Gregory Alan Korbel, SVP, Chief Operating Officer at Aprea Therapeutics, holds 45.76K shares in Aprea Therapeutics (Ticker: APRE).

Gregory Alan Korbel's Trading History

APRE
Aprea Therapeutics
Aug 01, 2022SVP, Chief Operating OfficerUninformative Buy―$18.58K
APRE
Insider Shares: 45.76K (0.20%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 01, 2022Uninformative Buy$0.0024,300$0.00―
Jun 07, 2022Uninformative Sell$6.71K8,390$0.80―
Mar 14, 2022Uninformative Sell$3.62K1,989$1.82―
Mar 14, 2022Uninformative Buy$0.0016,000$0.00―
Mar 01, 2022Uninformative Sell$2.31K1,326$1.74―

You May Also Like

Gregory Alan Korbel insider profile FAQ

What stocks does Gregory Alan Korbel hold?
Gregory Alan Korbel holds: APRE stocks.
What is Gregory Alan Korbel's role in Aprea Therapeutics?
Gregory Alan Korbel's role in Aprea Therapeutics is SVP, Chief Operating Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.